UBS Group’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-500	Closed	-$5.6K	–	9500
2024 Q4	$5.6K	Hold	500	–	–	﹤0.01%	7392
2024 Q3	$4.93K	Buy	+500	New	+$4.93K	﹤0.01%	6898
2023 Q2	–	Sell	-1,316	Closed	-$13.6K	–	8579
2023 Q1	$13.6K	Buy	+1,316	New	+$13.6K	﹤0.01%	6298